Senate Appropriations votes to reopen stem cell funding

06/21/2007 | Bloomberg

The day after the veto of a bill to ease restrictions on funding embryonic stem cell research, a Senate panel included expanded stem cell funding opportunities in an appropriations measure. The committee voted 26-3 to include in the $152 billion legislation funding several federal departments a provision that moves the date of eligible stem cell lines from August 2001 to June 15, sweeping in as many as 400 new lines.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO